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Abstract
Bacterial superantigens (SAgs) cause Vβ-dependent T-cell proliferation leading to im-
mune dysregulation associated with the pathogenesis of life-threatening infections such
as toxic shock syndrome, and necrotizing pneumonia. Previously, we demonstrated that
staphylococcal enterotoxin-like toxin X (SElX) from Staphylococcus aureus is a classical
superantigen that exhibits T-cell activation in a Vβ-specific manner, and contributes to the
pathogenesis of necrotizing pneumonia. Here, we discovered that SElX can also bind to
neutrophils from human and other mammalian species and disrupt IgG-mediated phagocy-
tosis. Site-directed mutagenesis of the conserved sialic acid-binding motif of SElX abolished
neutrophil binding and phagocytic killing, and revealed multiple glycosylated neutrophil
receptors for SElX binding. Furthermore, the neutrophil binding-deficient mutant of SElX
retained its capacity for T-cell activation demonstrating that SElX exhibits mechanistically
independent activities on distinct cell populations associated with acquired and innate immu-
nity, respectively. Finally, we demonstrated that the neutrophil-binding activity rather than
superantigenicity is responsible for the SElX-dependent virulence observed in a necrotizing
pneumonia rabbit model of infection. Taken together, we report the first example of a SAg,
that can manipulate both the innate and adaptive arms of the human immune system during
S. aureus pathogenesis.
Author summary
Staphylococcus aureus is a bacterial pathogen responsible for an array of disease types in
healthcare and community settings. One of the keys to the success of this pathogen is its
ability to subvert the immune system of the host. Here we demonstrate that the superanti-
gen (SAg) staphylococcal enterotoxin-like toxin X (SElX) contributes to immune evasion
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by inducing unregulated T-cell proliferation, and by inhibition of phagocytosis by neutro-
phils. We observed that the capacity to bind neutrophils appears to be central to the SElX-
dependent toxicity observed in a necrotising pneumonia infection model in rabbits. We
report the first example of a staphylococcal SAg with two independent immunomodula-
tory functions acting on distinct immune cell types.
Introduction
Staphylococcus aureus is an opportunistic pathogen responsible for a wide array of human dis-
eases in both the hospital and community settings [1]. The diversity of disease types and the
strain-dependent variation in pathogenic potential is due in part to the large array of virulence
factors that are produced by S. aureus [1]. The staphylococcal superantigens (SAgs) are a fam-
ily of at least 26 secreted proteins that modulate the immune system by stimulating dysregu-
lated T-cell proliferation [2–4], contributing to a variety of different diseases including toxic
shock syndrome, necrotizing pneumonia and Kawasaki disease [2]. The diversity of SAgs pro-
duced by S. aureus strains facilitates interaction with the large repertoire of variable-β chains
(Vβ) found in the T-cell receptor leading to dysregulation of a critical component of the adap-
tive immune response [2, 5].
The SAg SElX is encoded in the core genome of over 95% of S. aureus isolates and contrib-
utes to lethality in a rabbit model of necrotising pneumonia [6]. Although a member of the
SAg family, SElX exhibits greater sequence homology with the staphylococcal superantigen-
like protein (SSl) family comprising of proteins that are structurally similar to SAgs but lack
the capacity to induce Vβ-specific T-cell proliferation [5]. The SSls are associated with a diver-
sity of immune evasion functions including the blockade of complement activation, interfer-
ence with bacterial cell wall opsonisation (e.g. SSl7 and SSl10) and disruption of neutrophil
function (e.g. SSl3, SSl4 and SSl5) [7–11]. Of note, SSl5 can bind to neutrophils via a direct
interaction with CD162 (P-selectin glycoprotein ligand-1; PSGL-1), reducing neutrophil mi-
gration [7, 12], and SSl3 and SSl4 are toll-like receptor 2 antagonists which prevent neutrophil
activation by bacterial lipopeptides [11, 13, 14]. Fevre et al. (2014) previously demonstrated
that SElX can interact with neutrophils and monocytes, binding via the CD162 molecule on
the surface of neutrophils [15]. However, very high concentrations of SElX were required for a
relatively low-affinity interaction suggesting that CD162 may not be the main neutrophil re-
ceptor involved [15].
In addition to SSls, S. aureus produces other molecules which subvert the innate immune
response including chemotaxis inhibitory protein of staphylococcus (CHIPS), which binds to
the formylated peptide and C5a receptors on neutrophils, blocking chemotaxis to the site of
infection [16]. Furthermore, the formyl peptide receptor-like 1 inhibitor (FLIPr) and its homo-
logue FLIPr-like can antagonise the formylated peptide receptor and bind to Fcγ receptors dis-
rupting IgG-mediated phagocytosis of neutrophils [17, 18]. Other examples of multifunctional
determinants include; extracellular adherence protein (EAP) which can act as a host cell inva-
sin and inhibit the activity of neutrophil elastase, Panton–Valentine leucocidin (PVL) which
has been demonstrated to induce inflammation independent of cell lysis, and collagen binding
protein (CNA) which, in addition to its role binding to extracellular collagen, can bind C1q
and block the complement cascade [19–21]. These examples of multi-functionality highlight
the apparent functional redundancy exhibited by S. aureus with regard to pathogenesis,
providing a robust, multi-faceted response to innate immunity during the early stages of
infection.
SElX inhibits neutrophil function
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In the current study, we further investigated the role of SElX in S. aureus disease pathogene-
sis. We discovered that SElX binds to neutrophils via multiple glycosylated neutrophil surface
receptors, inhibiting phagocytosis and contributing to the pathogenesis of severe lung infec-
tion. Importantly, the neutrophil binding and superantigenic functions of SElX are mechanis-
tically independent providing a bi-functional disruption of both the innate and adaptive arms
of the human immune system.
Results
SElX binds to neutrophils and monocytes from multiple mammalian
species
In order to test the hypothesis that SElX can bind to human leukocytes, recombinant SElX was
incubated with human leukocytes isolated from healthy donors. SElX bound to both human
neutrophils and monocytes at a high level, comparable to or greater than the known neutro-
phil-binding protein SSl5 (Fig 1ii and 1iii). In addition, SElX exhibited low level binding to
CD4+ and CD8+ T-lymphocyte subsets but not to B-lymphocytes (CD19) (S1 Fig).
In order to examine the host-dependent binding of SElX, neutrophils from cattle, rabbits
and mice were employed. SElX exhibited a higher level of binding to murine neutrophils com-
pared to human neutrophils, but this was reduced compared to bovine and laprine neutro-
phils. However, binding to neutrophils from all species was observed at a concentration below
100 nM (Fig 1v, 1vi and 1vii). Overall SElX exhibited binding with neutrophils from multiple
mammalian species at a level that exceeded that of the known neutrophil-binding protein SSl5.
SElX binding to neutrophils is dependent on a conserved sialic acid-
binding motif
Amino acid sequence alignment of SElX with previously characterised SSl-proteins revealed a
conserved sialic acid-binding motif (YTxExxKxLQx[H/N/D]Rxx[D/E]) matching 54% amino
acid sequence identity with that of SSl5 (Fig 2) [7, 11, 22, 23]. Of note, 4 amino acids of the
motif have been demonstrated to interact with sialic-Lewis X (sLEX) [23], and 3 of these resi-
dues (E154, K156, and Q169) are conserved in SElX (Fig 2) and the 5 SSls that contain the
motif (Fig 2). The fourth residue ([H/N/D]161) identified to interact with sLEX in crystallog-
raphy studies [23], varies among the SSl-proteins and allelic variants of SElX encoded by dif-
ferent strains suggesting that this residue is not essential for sialic acid binding (Fig 2). SElX
exhibits considerable allelic variation, with at least 17 allelic variants, and a total of 40 (13%)
variable amino acid positions identified [6]. However the sialic acid binding motif contains
only one variable residue among all known allelic variants, consistent with functionality
(Fig 2).
To examine the hypothesis that SElX binding is sialic acid-dependent, neutrophils and
monocytes were pre-treated with neuraminidase prior to binding. Neuraminidase treatment
abolished the binding of SElX to both neutrophils and macrophages, suggesting that the inter-
action is sialic acid-dependent (Fig 3i). This is consistent with the observation of Fevre et al
(2014) who also noted a sialic acid requirement for SElX binding [15]. In order to investigate
the role of the predicted sialic acid-binding motif of SElX in neutrophil binding, single site-
directed mutants of each of the four predicted binding residues were constructed in addition
to a combination mutant of all four residues (Fig 3ii). Mutant proteins were expressed in E.
coli, purified and structurally validated by circular dichroism and thermal shift analysis to
ensure the mutations did not destabilise or influence protein structure (S2 Fig). Binding analy-
sis indicated that each of the SElX single site-directed mutants of E154A, K156A, Q169A and
SElX inhibits neutrophil function
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Fig 1. SElX binds to human monocytes and neutrophils from multiple mammalian species. Flow cytometry analysis of recombinant staphylococcal
proteins binding to isolated human cells. Cell type was determined by forward (FSC-H) and sideways (SSC-H) scatter (i). SElX binding to human
neutrophils (ii) monocytes (iii) and lymphocytes (iv) in addition to neutrophils isolated from mice (v), cattle (vi) and rabbits (vii), was examined. For all graphs
binding was detected using mouse anti-HIS-FITC IgG binding to the 6 x HIS-tag on the recombinant proteins. Mean median fluorescence of three donors is
shown ± standard error of the mean (SEM). SSl5 and SSl7 were used as positive and negative controls, respectively. The same legend is used for all
graphs.
https://doi.org/10.1371/journal.ppat.1006461.g001
SElX inhibits neutrophil function
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Fig 2. SElX protein sequence encodes a conserved sialic acid-binding motif. (i) A conserved glycan binding motif (colored red) is
present in the amino acid sequences of characterised SSl-proteins and SElX. (ii) The sialic acid-binding motif is conserved in all 17 alleles
of SElX. (iii) Amino acid conservation across the sialic acid-binding region of 7 staphylococcal neutrophil binding proteins (SSl2, SSl3, SSl4
SSl5, SSl6, SSl11 and SElX). The probability of residues at each position is proportional to the size of the letters. Image generated using
the weblogo 3.4 program (http://weblogo.threeplusone.com/). Chemical property color scheme: green is polar, blue is basic, red is acidic,
purple is neutral and black is hydrophobic. Sequences were obtained from previously published work [6, 23].
https://doi.org/10.1371/journal.ppat.1006461.g002
SElX inhibits neutrophil function
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Fig 3. SElX interaction with neutrophils is dependent upon the sialic acid binding motif. (i) Flow cytometry analysis of SElX binding to human
neutrophils and monocytes pretreated with 0.2 U/ml neuraminidase versus unteated cells. 6 x HIS-tagged SElX binding was detected using mouse anti-
His FITC-labelled IgG. (ii) Hypothetical protein model of SElX indicating the location of predicted sialic acid binding residues (colored green). The motif
residues are magnified in the black box to indicate their predicted atomic structure in the binding pocket. (iii) Flow cytometry analysis of site-directed
alanine-replacement mutants of SElX binding to human neutrophils. 6 x HIS-tagged SElX binding was detected using Mouse anti-HIS FITC-labelled IgG.
https://doi.org/10.1371/journal.ppat.1006461.g003
SElX inhibits neutrophil function
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the combination mutant SElX-EKQD-A exhibited almost complete loss of binding to both
neutrophils and monocytes compared to the wild-type SElX protein, indicating that each of
these 3 residues are required for SElX-mediated neutrophil and monocyte binding (Fig 3iii).
The mutant SElX-D161A did not demonstrate a reduction in neutrophil or monocyte binding
compared to wild-type SElX, indicating that this residue is not required for neutrophil or
monocyte binding (Fig 3iii). Taken together these data demonstrate that the predicted sialic
acid-binding motif of SElX is essential for binding to both human neutrophils and monocytes.
SElX interacts with multiple neutrophil glycoprotein receptors
In order to identify the receptors for SElX-binding on the surface of neutrophils, affinity pre-
cipitation analysis of recombinant SElX and the neutrophil binding-deficient SElX-EKQD-A
mutant was carried out with human neutrophil lysates, followed by quantitative mass spec-
trometry (MS) analysis. At least 12 proteins were enriched 5-fold or higher on SElX-coated Ni-
NTA beads compared to Ni-NTA beads coated with SElX EKQD-A mutant protein suggesting
that SElX binds to many neutrophil receptors in a sialic-acid dependent manner (S1 Table; Fig
4i). To test the hypothesis that individual neutrophil receptors could support binding of SElX
we performed an ELISA-type assay with recombinant SElX and recombinant CD50 (ICAM-
3), a protein that was enriched in the affinity precipitation analysis (Fig 4ii). The data demon-
strated that SElX could bind directly to immobilized CD50 in a manner dependent on the
sialic-acid binding motif (Fig 4ii).
All of the cell surface proteins identified to bind SElX are glycoproteins, consistent with
the requirement for sialic-acid binding and represent an array of functional pathways in the
neutrophil. Of note, the most enriched proteins are glycoproteins that display integrin or cell
activation functions (CD45, CD13, CD31, CD50 and CD148) [24–27]. In addition, several
cytosolic or granule-associate proteins were identified to bind to SElX, including p22-PHOX
and the enzyme maltase-glucoamylase (MGAM) (found in the gelatinase and ficolin granules
of neutrophils), both of which are involved in microbicidal functions of neutrophils [28, 29].
SElX inhibits phagocytosis and killing by human neutrophils in a manner
independent of its superantigenic function
To determine if SElX inhibits neutrophil-mediated phagocytosis of S. aureus, neutrophils were
pre-incubated with SElX before the addition of opsonised bacteria. SElX reduced the ability of
neutrophils to take up bacteria when heat-inactivated human pooled serum (ΔHPS) or IgG
alone were applied as opsonins (Fig 5i). These data demonstrate that IgG-mediated phagocyto-
sis is inhibited by SElX independently of the complement-mediated phagocytic pathway. SElX
exhibits a highly potent activity at a concentration as low as 20 nM with a reduction in phago-
cytosis of up to 30%, compared to up to 70% for the Fcγ antagonist FLIPr (Fig 5ii). Of note, no
reduction in phagocytosis was observed when the SElX EKQD-A mutant was pre-incubated
with neutrophils (Fig 5ii), consistent with a requirement for sialic acid-binding dependent
neutrophil interactions for phagocytosis inhibition.
To test the hypothesis that SElX enhances S. aureus survival in the presence of neutrophils,
S. aureus strain USA300 LAC, a derivative selx deletion mutant, or a derivative that produces
SElX-EKQD-A (Table 1, see S3 Fig for mutant validation) were each incubated with human
neutrophils. The USA300 LAC parent strain was highly resistant to neutrophil killing consistent
with previous reports [30, 31], but the selx deletion mutant and EKQD-A-expressing derivatives
both exhibited increased susceptibility to killing (Fig 5iii). Importantly, re-introduction of selx
to the LACΔselx mutant restored killing resistance to wild-type levels (Fig 5iii). These data indi-
cate that SElX enhances the capacity of S. aureus to survive neutrophil-mediated killing.
SElX inhibits neutrophil function
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To determine if the superantigenic activity of SElX is distinct from its capacity to bind to
neutrophils and inhibit phagocytosis, sialic acid-binding mutants of SElX were examined for
their ability to induce T-cell proliferation by [3H] thymidine incorporation (Fig 6). All 5
Fig 4. SElX binds to multiple neutrophil surface glycoproteins in a sialic acid-dependent manner. (i) Neutrophil lysates were analysed for
peptide enrichment following incubation with wild-type SElX (WT) and SElX EKQD-A. Data shown indicates the mean number of peptides detected
from each enriched protein (± SD from three donors). * denotes significance difference (p-value <0.05) in peptide enrichment between the wild-type
and mutant protein as determined by multiple t-test comparisons (one unpaired, two tailed test per protein), without assuming similar standard
deviation. (ii) ELISAs were performed comparing the interaction between staphylococcal proteins and recombinant CD50. Two-way ANOVA
statistical analyses were performed. **** denotes a significant difference between SElX and SElX EKQD-A.
https://doi.org/10.1371/journal.ppat.1006461.g004
SElX inhibits neutrophil function
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Fig 5. SElX inhibits IgG-mediated neutrophil phagocytosis and reduces killing by human neutrophils. (i)
Phagocytosis of fluorescent-labelled S. aureus opsonized with 150 μg/ml of purified human IgG or 1% (v/v)
SElX inhibits neutrophil function
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mutants were capable of inducing T-cell proliferation at comparable levels inferring that the
residues essential for neutrophil binding are not required for superantigenic activity. These
data indicate that SElX exhibits two independent mechanisms of immune modulation affect-
ing distinct cell types.
SElX does not contribute to the severity of murine skin abscess
infections
To examine the role of SElX-neutrophil binding in the pathogenesis of skin infections, we car-
ried out experimental murine skin abscess infections with USA300 LAC and derivative mutant
strains (Table 1). Lesions developed within 24 h post injection and generally reached peak size
within three days. No differences were seen in lesion size between the different mutant groups
and the number of bacteria recovered at each time point declined over the course of the study
up to 144 h (Fig 7). At each time point there were no differences seen in bacterial load between
the different mutant and wild-type groups (Fig 7). For histopathological analysis, 6 mice were
analysed from each experimental cohort and infected animals were sacrificed at 72 and 144 h
post infection. Processed tissue slides were assessed for abscess morphology, severity of tissue
damage and leukocyte infiltration. Diversity was observed in terms of both lesion morphology
and severity although these features were not associated with a particular bacterial genotype
(Fig 7). High levels of leukocyte infiltrations were observed in all slides but no differences
complement-inactivated human pooled serum (ΔHPS), in the presence of SElX at various concentrations. Gates
indicate the populations of neutrophils that have phagocytosed bacteria or not (+/-). (ii) Inhibition by recombinant
SElX protein was compared to the IgG-mediated phagocytosis inhibitor FLIPr and the neutrophil-binding deficient
mutant SElX EKQD-A. Phagocytosis was calculated as the percentage of cells with fluorescent bacteria and
expressed relative to buffer-treated cells with 75 μg/ml human IgG. Results shown are the means of three
different human donors (error bars SE of mean). Results between SElX wild-type and SElX EKQD-A protein were
tested by two-way ANOVA and found to be significantly different, *indicates at which concentration a significant
difference in phagocytosis was observed. (iii) S. aureus USA300 wild-type, selx deletion and site-directed
mutants were incubated with isolated human neutrophils for 60 min. Following incubation neutrophils were lysed
with Triton-X 100 and surviving bacteria plated and enumerated. Killing was calculated as the difference between
the no neutrophil control and the surviving CFU. Data shown are the mean % surviving bacteria incubated with
cells from 5 donors ± SD. CFU data were tested by students t-test (unpaired, two-tailed) with Welches correction,
(* indicates a p value < 0.05, ** indicates a p value < 0.01).
https://doi.org/10.1371/journal.ppat.1006461.g005
Table 1. Bacterial strains used in this study.
Strain Description Source/Reference
S. aureus
USA300 LAC Wild-type, Erythromycin (ERM) sensitive [32]
USA300 LACΔselx Deletion of selx, ERM sensitive [6]
USA300 LACΔselx repaired
(rep)
Reintroduction of selx, ERM sensitive [6]
USA300 LAC selx EKQD-A Re-introduced selx, with site-directed mutations of the sialic acid-binding motif, ERM
sensitive
This Study
USA300 spa::Tn Transposon insertion into spa [33]
E. coli
DH5α Cloning strain Invitrogen, Paisley, UK
BL21 DE3 Expression strain Invitrogen, Paisley, UK
Strataclone SoloPack lacZΔM15 mutation, endA, recA-deficient Agilent Technologies,
UK
https://doi.org/10.1371/journal.ppat.1006461.t001
SElX inhibits neutrophil function
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detected among the different mutants groups in comparison to LAC wild-type infected tissue
(Fig 7). Taken together, these data indicate that selx does not contribute to virulence in this
murine skin abscess infection model.
SElX-associated virulence in a rabbit model of necrotising pneumonia is
dependent on the sialic-acid binding residues
Previously, SElX has been demonstrated to contribute to lethality in a rabbit model of necrotis-
ing pneumonia [6]. Here, the experiment was repeated including the selx-EKQD-A-expressing
USA300 LAC to examine the relative contribution of superantigenicity and neutrophil-bind-
ing functions of SElX to the outcome of infection. At an inoculum of 6 x 109 CFU, rabbits
infected with LACΔselx or LAC selx EKQD-A had longer survival times (Fig 8i) and had less
elevated body temperatures than animals infected with wild-type LAC or repaired strain
(LACΔselx rep) (Fig 8iii). Similarly, at a lower inoculum of 2 x 109 CFU animals challenged
with the LAC selx EKQD-A mutant strain had increased survival (p = 0.0027; Fig 8ii) and less
elevated body temperature compared to animals infected with the wild-type (p = 0.0014; Fig
7iv). On gross examination, lungs from rabbits infected with wild-type LAC were dark red to
purple indicating severe haemorrhage (Fig 8v left). In contrast, lungs from rabbits infected
with the LAC selx EKQD-A mutant strain demonstrated signs of haemorrhage in one lobe but
tissue was relatively healthy in the second lobe (Fig 8v right). Taken together, these data indi-
cate that residues essential for sialic acid-binding of SElX are required for the pathology caused
by SElX in a rabbit model of necrotising pneumonia. As a role for SElX in pathogenesis in a
murine skin abscess model was not observed in the current study, these data highlight impor-
tant host- or tissue-specific differences relevant to the choice of infection model employed for
investigating S. aureus pathogenesis.
Fig 6. Neutrophil binding-deficient mutants of SElX retain mitogenic activity. Isolated human PBMC were
stimulated with recombinant SElX and sialic acid-binding mutants. After 72 h incubation, proliferation was determined by
analysing the incorporation of [3H] thymidine. Results shown are the means of triplicate measurement from 3 human
donors ± standard deviation of the mean.
https://doi.org/10.1371/journal.ppat.1006461.g006
SElX inhibits neutrophil function
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Fig 7. SElX does not contribute to S. aureus virulence in a mouse skin abscess infection model. (i) Lesion size of each mouse
(n = 10) was measured every 24 h post inoculation (p.i.) for 6 d. Mean lesion size ± SEM is plotted for each of the 4 USA300 LAC mutant
SElX inhibits neutrophil function
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Discussion
As previously reported in Wilson et al (2011), SElX shares sequence homology with SAgs and
SSls, suggesting that SElX may have properties of both families of proteins. In this study we have
demonstrated that SElX exhibits characteristics of both groups and can therefore be described as
a functional hybrid of the SAgs and SSls. SElX is a bi-functional protein that binds to neutrophils
and inhibits IgG-mediated phagocytosis via a mechanism that is distinct from its superantigenic
activity. This is the first time that bi-functionality has been observed in superantigens indepen-
dent of the emetic activity of staphylococcal enterotoxins. The common multifunctionality of S.
aureus virulence factors is an emerging theme in S. aureus pathogenesis research. For example,
SSl5 binds to neutrophils via PSGL-1 and also inhibits the function of metalloprotease 9 result-
ing in the inhibition of cell activation by chemokines, rolling and migration of neutrophils to
the site of infection, and reduction in the formation of thrombi [34–38]. In addition, Staphylo-
coccal protein A (SpA) subverts opsonisation by binding the Fc region of IgG molecules and
can also act as a SAg for B-lymphocytes leading to disruption of the humoral immune response
[39]. Cytolytic toxins from S. aureus (including Hla, HlgACB, PVL and LukAB) in addition to
their cytolytic activity on haematopoietic cells have been shown at sub-lytic concentrations to
activate the intracellular NOD-like Receptor protein 3 (NLRP3) inflammasome in neutrophils,
monocytes and macrophages which lead to pro-inflammatory cytokine release [21, 40–44]. Of
note, we have identified a protein that employs distinct mechanisms to target two distinct
immune cell types linked to innate and acquired immune responses, respectively.
The SaeRS two-component system controls an array of S. aureus virulence factors such as
CHIPS, SCIN, the SSls, and SAgs including TSST-1, which are involved in immune evasion in
response to host stimuli [45–47]. Transcriptomic analysis of a USA300 deletion mutant of
SaeRS, performed by Nygaard et al, resulted in almost a five-fold decrease in the transcription
levels of selx (SAUSA300_0370) [47]. These data suggest that selx is regulated by SaeRS in co-
ordination with an array of other immune modulators. Considering its dual modes of func-
tion, SElX is likely produced by S. aureus early in infection in response to neutrophil signals
but may persist at the site of infection as the adaptive immune response is recruited, leading to
induction of T-cell proliferation and further immune dysregulation. Alternatively, SElX activa-
tion of lymphocytes resulting in the release of cytokines and chemokines (such as interferon-γ
and interleukin 6) may stimulate the recruitment of neutrophils, as reported previously for
SEA [48]. As neutrophils are recruited to form an abscess, SElX may enhance bacterial survival
by inhibiting phagocytosis and stimulating misdirecting cytokines from lymphocytes which
could also inhibit neutrophil function. We observed that SElX exhibited low levels of binding
to human lymphocytes and this was limited to CD4+ and CD8+ T-cells with no binding to B-
lymphocytes (S1 Fig). This is a characteristic of the SSl-proteins that bind to human leukocytes
and may reflect the low activity of glycosyl-transferases in peripheral lymphocytes prior to acti-
vation [49]. In lymphocytes, glycosyl-transferases are activated by the presence of IL-2, an
interleukin induced during SAg-mediated activation of the lymphocyte [49]. It is possible that
SElX induces glycosylation on the surface of lymphocytes through SAg-mediated activation
and then acts as a glycoprotein antagonist modulating lymphocyte function. However, further
experiments would be required to investigate this hypothesis.
groups. (ii) Bacteria were recovered from excised skin lesions and enumerated by serial dilutions. CFU were normalised to the weight of
tissue homogenised to give the bacterial load per mg of tissue. CFU per mg are displayed for each infected animal; the horizontal line
indicates the mean CFU/mg of tissue and vertical bars show the SEM for each group (n = 10) (iii) Representative images from
histological examinations of skin lesions 72 h and 144 h post inoculation. Mounted sections were stained with haematoxylin and eosin.
Black arrows on each image indicate the surface of the epidermis.
https://doi.org/10.1371/journal.ppat.1006461.g007
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SElX demonstrates the ability to interact with neutrophils from multiple mammalian species
including humans, rabbits, mice, and cattle. Dairy cows and farmed rabbits represent important
veterinary hosts of S. aureus [50] and the ability of SElX to bind to neutrophils from these spe-
cies, in addition to humans, suggests a broad role for SElX in pathogenesis of S. aureus mamma-
lian hosts (Fig 1). Previous studies of S. aureus virulence have demonstrated that rabbits may
represent more appropriate infection models than mice for the analysis of some virulence fac-
tors such as Panton-Valentine leucocidin (PVL) [51]. Although we identified that SElX bound
strongly to murine neutrophils, we did not detect any SElX-dependent effect on virulence in a
murine skin abscess model (Fig 7). This may reflect low levels of SElX expression during murine
skin infection or alternatively it may be due to the previously observed differential glycan deco-
ration on murine cell receptors compared to humans [52–55], which could impact on the
capacity of SElX to bind to specific target receptors with downstream pathogenic consequences.
Our data suggest that the effect of SElX on neutrophils is independent of cytolysis and apo-
ptosis (S4 Fig) and that it can mediate an inhibition of IgG-mediated phagocytosis, consistent
with its capacity to bind to the Fcγ receptor CD16b. However, the observed promiscuous bind-
ing of SElX to an array of glycosylated neutrophil proteins suggests that SElX may disrupt
other neutrophil functions. For example, another SElX binding partner ICAM-3 (CD50) is an
important signalling molecule associated with the lymphocyte function-associated antigen 1
(LFA-1) which was also identified as a ligand for SElX (α-L integrin) [56, 57]. In addition, sev-
eral proteins linked to the phagosome including MGAM (a glucamase present in neutrophil
granules) [29] and p22-PHOX (a key component of the cytochrome B complex) [28] were able
to bind to recombinant SElX in a sialic acid dependent manner (Fig 4), suggesting that SElX
may interfere with neutrophilic enzymes involved in phagosomal killing.
The multiple functions exhibited by many S. aureus virulence factors contribute to the
remarkable apparent redundancy of function promoting the evasion of the immune response.
This is an important consideration for the development of vaccines and anti-virulence therapy as
therapeutic or preventive measures targeting a small number of virulence factors may prove inef-
fective if similar functions can be mediated by alternative proteins. Therefore, developing an
understanding of the full functional repertoire of S. aureus virulence factors will inform the ratio-
nal design of targeted therapies that by-pass the intrinsic redundancy in S. aureus pathogenesis.
In conclusion, we have demonstrated that SElX is a bi-functional SAg with distinct modula-
tory effects on critical functions of the innate and acquired immune response. Given the large
family of SAgs identified to date, our findings imply that further investigations into the alter-
native functions of SAgs are warranted.
Material and methods
Ethics statement
Human venous blood was taken from healthy donors in accordance with a human subject pro-
tocol approved by the national research ethics service (NRES) committee London City and
Fig 8. SElX contributes to lethality in a rabbit model of necrotising pneumonia by inhibiting neutrophil function. Kaplan-
Meier curves of % survival of rabbits infected with wild-type S. aureus LAC, LACΔselx, LACΔselx rep and LAC selx EKQD-A at a dose
of 6x109 CFU (i) and S. aureus LAC and LAC selx EKQD-A at a dose of 2x109 CFU (ii), p-values stated are the results of log-rank
(Mantel-Cox) tests. (iii) Increase in rabbit core temperature (ΔT˚C) 12 h after pulmonary infection with LAC, LACΔselx, LACΔselx rep
and LAC selx EKQD-A at a dose of 6x109 CFU (data plotted are the mean of three animals ± SD). (iv) Increase in rabbit core
temperature (ΔT˚C) 12 h after pulmonary infection with LAC and LAC selx EKQD-A at a dose of 2x109 CFU (data plotted are the
mean of four animals ± SD, ** indicates statistical significance by unpaired, two-tailed students t-test p<0.003) (v) Gross pathology of
lungs from rabbits infected with S. aureus strain LAC and LAC selx EKQD-A showing representative examples of haemorrhagic
lesions.
https://doi.org/10.1371/journal.ppat.1006461.g008
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East under the research ethics committee reference 13/LO/1537. Volunteers were recruited by
a passive advertising campaign within the Roslin Institute (University of Edinburgh) and fol-
lowing an outline of the risks, written informed consent was given by each volunteer before
each sample was taken. De-identified human blood packs from consenting-healthy individuals
were also purchased from the New York Blood Center. The New York City Blood Center
obtained written informed consent from all participants involved in the study and risks were
outlined to each donor prior to sampling. The use of the de-identified samples was reviewed
and approved by the New York University School of Medicine University Committee on
Activities Involving Human Subjects.
All experiments using animals were handled in strict accordance with good animal practice
as defined by the relevant national and local animal welfare bodies. Specifically, experimenta-
tion using rabbits were performed under a University of Iowa approved Institutional Animal
Care and Use Committee (IACUC) protocol (4071100). Animals were maintained in accor-
dance with the Animal Welfare Act (1966) (administered by the US Department of Agricul-
ture) and the U.S. Department for Health and Human Services (DHHS) ‘‘Guide for the Care
and Use of Laboratory Animals”. University of Iowa is accredited by the Association for
Assessment and Accreditation of Laboratory Animal Care International (AALAC). For intra-
pulmonary administration of bacterial strains, animals were anesthetized with use of ketamine
(10 mg/kg) combined with xylazine (10 mg/kg). In agreement with the University of Iowa
IACUC, animals that failed to exhibit escape behaviour and at the same time could not right
themselves were prematurely euthanized according to predetermined experimental endpoints.
Animals were euthanized with intravenous injection of 2 ml of Euthasol, whether prematurely
or at the end of experimentation. Euthanized animals were then subjected to bilateral thoracot-
omy to ensure euthanasia. All animals received pain-relieving medication (buprenorphine;
0.05 mg/kg intramuscular twice daily) for the duration of experimentation.
All murine experiments were carried out under the authority of a UK Home Office Project
License (PPL 70/08663) within the terms and conditions of the regulations of the UK Home
Office Animals (Scientific Procedures) Act 1986 and the code of practice for the housing and
care of animals bred, supplied, or used for scientific purposes. The study protocol was reviewed
and approved by the Roslin Institute Small Animal Review Group (University of Edinburgh)
which includes the Named Veterinary Surgeon (NVS), Named Animal Care and Welfare Offi-
cers (NACWOs) and a statistician services prior to each experiment. Animals were monitored
twice daily to ensure that no animal exceeded predetermined severity agreed euthanasia crite-
ria according to the study protocol. Animals were euthanized, whether prematurely or at the
end of experimentation by asphyxiation using carbon dioxide. Euthanized animals were then
subjected to cervical dislocation to ensure euthanasia.
Chicken immunisation was provided by the Scottish national blood transfusion service
(Pentland Science Park, Midlothian, UK) using unembryonated hen’s eggs. Procedures per-
formed were carried out under the authority of a UK Home Office Project License (PPL 60/
4165) within the terms and conditions of the regulations of the UK Home Office Animals (Sci-
entific Procedures) Act 1986 and the code of practice for the housing and care of animals bred,
supplied, or used for scientific purposes.
Bacterial strains and culture conditions
S. aureus strains were cultured in tryptone soya broth (TSB) or brain heat infusion broth
(BHI) (Oxoid, UK) with shaking at 200rpm, or on tryptone soya agar (TSA) (Oxiod, UK) at
37˚C for 16 h unless otherwise stated. E. coli strains were cultured in Luria broth (LB) (Melford
laboratories, UK) with shaking at 200rpm, or on LB-agar (Melford laboratories, UK) at 37˚C
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for 16 h unless otherwise stated. Media was supplemented, where appropriate, with antibiotics.
Strains were stored in the appropriate liquid culture media containing 40% (v/v) glycerol
(Sigma-Aldrich, UK) in cryovials (Nunc, Thermo Scientific, UK) at -80˚C.
Leukocyte isolation
50 ml of venous blood was drawn from healthy human volunteers and mixed with 6 ml of
acid-citrate-dextran (ACD) (25 g D-glucose (Sigma-Aldrich, UK) and 20.5 g trisodium citrate
(Sigma-Aldrich, UK) added to 1 L of ddH2O). Human neutrophils and peripheral blood
mononuclear cells (PBMC) were isolated as outlined previously [58] and re-suspended in
RPMI1640 (Gibco, UK) containing 0.05% human serum albumin (HSA) (Sigma Aldrich, UK)
for further analysis.
Murine bone marrow derived neutrophils were isolated from femurs of wild-type mice
from BALB/C backgrounds, as described previously [59]. Neutrophil cell identity was con-
firmed using Lys6C and Lys6G staining by incubating the isolated cells with 1:500 dilutions of
Rat anti-Lys6C PerCP-Cy5.5 (AL-21; BD Bioscience, Oxford, UK) and Rat anti-Lys6G PE-Cy7
(1A8; BD Bioscience, Oxford, UK) for 30 min on ice and then analysed by flow cytometry
(FACSCalibur; Becton Dickinson, Franklin Lanes, NJ). Expression of neutrophil cell surface
markers was confirmed by a high fluorescent signal for Lys6G and Lys6C.
Bovine neutrophils were isolated from Holstein-Friesian cattle aged 18 to 36 m via jugular
vein puncture (6 ml 10 x PBS/EDTA (100 mM KH2PO4, 9% (w/v) NaCl, and 2 mg/l EDTA in
sterile H2O adjusted to pH 7.4) anticoagulant used for 50 ml of blood). Neutrophils were iso-
lated from bovine blood using a previously described protocol [60].
Rabbit neutrophils were isolated from peripheral rabbit blood (using ACD as an anticoagulant)
purchased from the National Transfusion Centre, Moredun Institute, Midlothian, UK. Leukocytes
were isolated using an equal volume of red blood cell (RBC) lysis buffer (10 x buffer contained;
155 mM NH4Cl, 10 mM KHCO3 and 100 μM EDTA in ddH2O). RBCs were lysed in 1x lysis
buffer for 10 min at 37˚C and the remaining cells were pelleted at 400 x g for 10 min and washed
with HBSS (Mg2+ and Ca2+ free) (Gibco) and this was repeated until the pellet was clear of RBCs.
All cells were counted with a TC20 automated cell counter (Biorad, Hemel Hempstead, UK) and
re-suspended to a concentration of 1 x 107 cells/ml in the desired assay media/buffer.
Western blot analysis
Liquid cultures of S. aureus strains were grown in BHI broth to stationary growth phase
(OD600 = 4.0–7.0). Cultures supernantants were concentrated using Amicon Ultra-15 Centrif-
ugal Filter units (10000 MWCO) (Millipore, Watford, UK). Concentrated secreted proteins
were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE,
12% acrylamide gel) and transferred to nitrocellulose membranes using the Trans-Blot Turbo
Blotting system (Bio-Rad, Hemel Hempstead, UK), according to the manufacturer’s specifica-
tions. The membrane was incubated in 1 x PBS (pH 7.3) containing 8% (w/v) powdered milk
(Sigma-Aldrich, UK), at 4˚C overnight. The membrane was incubated with primary antibody
(anti-SElX chicken IgY), at a dilution of 4μg/ml for 2 h. Anti-SElX IgY was obtained from
immunised unembryonated hen’s eggs using the Eggspress IgY purification kit (Gallus Immu-
notech, NC, USA) according to the manufacturer’s instructions. Following primary antibody
incubation the membrane was washed 3 times with washing buffer, 1 x PBS (pH 7.3) contain-
ing 1% (w/v) powdered milk and 0.05% (v/v) Tween 20 (Sigma-Aldrich, UK). The membrane
was incubated with a horse radish peroxidase-conjugated (HRP) secondary antibody (goat
anti-chicken-IgY IgG (Source Bioscience, Nottingham, UK)), at 0.5 μg/ml in washing buffer,
for 1 h, followed by a further 3 washes and then incubated with ECL reagent for 5 min. The
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blot was then exposed on Hybond ECL film (Amersham, Systems, Buckinghamshire, UK) for
20 s and developed using an X-ray developer (SRX-101A, Konic Minolta, Japan).
Recombinant protein expression
E. coli expression strain BL21 DE3 containing plasmid constructs (pET15b::selx2, pET15b::ssl7
[6], and pRSETB::ssl5 [12]) for protein expression were cultured in LB containing selective
antibiotics and induced in mid-exponential phase of growth (OD600 = 0.6), with 1 mM isopro-
pyl b-D-1-thiogalactopyranoside (IPTG) (Formedium Ltd., Norfolk, UK) for 4 h at 37˚C. Cells
were recovered by centrifugation at 4000 x g, disrupted using a One-Shot cell disruptor (Con-
stant Systems, Northants, UK), and His-tagged recombinant proteins were purified by affinity
chromatography on a His-Trap FF crude nickel affinity column (GE healthcare, Buckingham-
shire, UK) using an AKTA fast protein liquid chromatography (FPLC) OPC900 P920 system
(GE Healthcare, Buckinghamshire, UK). SSl5 was purified using the buffer system outlined
previously [9]. SSl7 purification was performed using a buffer containing 50 mM NaH2PO4,
300 mM NaCl and 10 mM imidazole (pH 8.0). For washing, imidazole concentration was
increased to 20mM and a concentration of 250 mM imidazole was used for elution. SElX was
purified under denaturing conditions in a lysis buffer of 100 mM NaH2PO4, 10 mM Tris•Cl
and 8 M urea (pH 8), the protein was washed with the same buffer at pH 6.3 then eluted at a
pH of 4.5. To further purify SElX, ion exchange chromatography was used by diluting the
affinity chromatography elution (1/10) in 50 mM HEPES (pH 7.5) and binding it to a Hitrap
SP FF column. Protein was eluted over a NaCl gradient. Purified proteins were dialysed in 1 x
PBS (pH 7.3) using Spectra/Por Float-A-Lyzer tubing with an 8000 to 10000 Da molecular
weight cut off (MWCO) (Spectrum Laboratories, CA, USA). Proteins were quantified using a
Nano-Drop ND1000 spectrophotomer (Thermo scientific, USA) set on the A280 program.
After the protein solution spectra were obtained, the concentration of the protein was calcu-
lated at an absorbance of 280 nm and the extinction coefficient calculated from the protein
sequence as described previously [61].
Flow cytometry binding analysis
For binding of recombinant proteins to leukocytes, neutrophils (5 × 106 cells/ml) and PBMCs
(5 × 106 cells/ml) were incubated with increasing concentrations of 6 x HIS-tagged recombi-
nant proteins in RPMI 1640 (Gibco, UK) and 0.05% HSA (human serum albumin (Sigma-
Aldrich, UK), RPMI-HSA) for 30 min on ice. For some leukocyte binding experiments the
cells were also co-incubated with cell surface subset–specific antibodies including anti-CD4
(Leu-3a), -CD8 (Leu-2a), and, -CD19 (Leu-12) (PE labelled) (BD bioscience, Oxford, UK).
Cells were washed with RPMI-HSA and pelleted at 400 x g for 10 min at 4˚C. Binding of the
proteins was detected with a FITC-labelled monoclonal mouse anti-HIS tag monoclonal anti-
body at a 1.25 μg/ml final concentration (AD1.1.10; LS Bioscience, WA, USA), antibodies
were incubated with cells for 30 min on ice, washed with RPMI-HSA and pelleted at 400 x g
for 10 min at 4˚C. Following washing, cells were re-suspended in 200 μl of RPMI-HSA and
leukocyte populations were identified based on forward and sideway scatter on a BD FACSCa-
liburflow cytometer (Becton Dickinson, Franklin Lanes, NJ), and fluorescence was measured.
To analyse leukocyte apoptosis, cells were washed one additional time following the binding
experiment and re-suspended in assay media containing the nuclear dye DRAQ 5 (Biostatus,
UK) (diluted 1/250) prior to flow cytometry analysis. For neuraminidase experiments, isolated
leukocytes (2 x 106 cells/ml) were pre-treated with 0.2 U/ml neuraminidase (from Vibrio chol-
era; Sigma-Aldrich, UK) at 37˚C for 45 min at pH 6.0, prior to washing and subsequent incu-
bation with proteins.
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Site directed mutagenesis
Site-directed mutagenesis was performed to exchange amino acids in the sequence of SElX
with alanine by introducing mutations into the pET15b::selx2 construct using PCR with oligo-
nucleotide primers listed in Table 2. The reactions were performed using the PfuUltra II
Fusion HS DNA polymerase (Agilent Technologies, UK). Primers were used at a final concen-
tration of 250 nM along with 2 mM dNTPs (Promega, Hampshire, UK). PCR cycle conditions
were as follows; 1 cycle at 95˚C for 2 min, 30 cycles of 95˚C for 20 s, 50˚C for 20 s and 72˚C for
90 s, followed by a final extension of 3 min at 72˚C. Following the PCR reaction, DpnI endonu-
clease (NEB, Herts, UK) was added to a final concentration of 0.8 U/μl, the reaction was then
incubated for 1 h at 37˚C followed by an enzyme deactivation step of 10 min at 65˚C. Follow-
ing digestion, 1 μl of the amplified vector product was transformed into E. coli Solopack cells
from the Strataclone blunt cloning kit (Agilent technologies, UK) following the manufacturer’s
instructions. Transformation plates were incubated overnight at 37˚C and screened for trans-
formed colonies, which were randomly selected for Sanger sequencing (Edinburgh Genomics,
Table 2. List of primers used in this study.
Primer
Namea,b
Sequence (5’-3’) Nucleotide
Mutationc
Amino Acid
Exchange
Cloning Primers
pMAD
MCS F
GCAACGCGGGCATCCCGATG
pMAD
MCS R
CCCAATATAATCATTTATCAACTCTTTTACACTTAAATTTCC
T7(pET
MCS) F
TAATACGACTCACTATAGGG
T7(pET
MCS) R
GCTAGTTATTGCTCAGCGG
selx seq
F
AGGTATCATCTATGGGGGAACA
selx seq
R
ATGATGGTGCTAATCATAACAAAGA
selx out F ATGTGGCTAATTTTGTTCGAGTCG
selx out
R
CGTCATGCGTTACTTTCGTTCG
Site-directed Mutagenesis
E153 F GTCATAAATACAAAAGATGGTGGTAAATATACATTAGCTTCGCATAAAGAGCTACAAAAAGATAGGG 499 GAG>GCT E153A
E153 R CCCTATCTTTTTGTAGCTCTTTATGCGAAGCTAATGTATATTTACCACCATCTTTTGTATTTATGAC
K156 F GATGGTGGTAAATATACATTAGAGTCGCATGCAGAGCTACAAAAAGATAGGGAAAAT 508 AAA>GCA K156A
K156 R ATTTTCCCTATCTTTTTGTAGCTCTGCATGCGACTCTAATGTATATTTACCACCATC
Q159 F GAGTCGCATAAAGAGCTAGCAAAAGATAGGGAAAATGTAAAAA 517 CAA>GCA Q159A
Q159 R TTTTTACATTTTCCCTATCTTTTGCTAGCTCTTTATGCGACTC
D161 F GAGTCGCATAAAGAGCTACAAAAAGCAAGGGAAAATGTAAAAATT 524 GAT>GCA D161A
D161 R AATTTTTACATTTTCCCTTGCTTTTTGTAGCTCTTTATGCGACTC
EKQD F GGTGGTAAATATACATTAGCTTCGCATGCAGAGCTAGCAAAAGCAAGGGAAAAT 499 GAG>GCT 508
AAA>GCA 517
CAA>GCA 524
GAT>GCA
E153A
K156A
Q159A
D161A
EKQD R ATTTTCCCTTGCTTTTGCTAGCTCTGCATGCGAAGCTAATGTATATTTACCACC
a F and R refer to forward and reverse primers respectively
b Multiple cloning site (MCS)
c Positions relative to selx2 allele (NCBI gene accession: SAUSA300_RS01970)
https://doi.org/10.1371/journal.ppat.1006461.t002
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University of Edinburgh). When the mutations were confirmed the plasmid constructs were
transformed into BL21 DE3 E. coli cells for protein expression and purification. Following the
purification of the mutated proteins, analysis was performed to show the proteins had folded
correctly and not become unstable. Far UV circular dichroism (CD) spectra of samples were
acquired on a Jasco J-710 spectrometer (Japan Spectroscopic Co. Ltd, Japan). Spectra of the
proteins, at a concentration of 0.4 mg/ml to 1 mg/ml in 0.1 x PBS (pH 7.3), was recorded
between 190 nm to 250 nm using a cuvette with a path length of 0.05 mm. Thermal shift ana-
lysis was performed using SYPRO Orange dye (Life technologies, UK) and conducted in a
Lightcycler 480 (Roche, West Sussex, UK) using the melt curve function from 25˚C to 95˚C.
Solutions of 5 μM recombinant staphylococcal protein were mixed with SYPRO Orange dye
diluted 1/125 of the stock dye. The plate was heated from 25˚C to 95˚C in temperature incre-
ments of 0.1˚C/sec. The fluorescence intensity was measured with excitation/emission at 465/
510 nm.
To prepare an S. aureus construct containing the site-directed mutations in selx the same
PCR protocol was applied to pMAD::selx rep [6] as described previously for pET15b::selx2.
Following confirmation of the mutations by sequencing, pMAD::selx EKQD-A was trans-
formed into S. aureus RN4220, then transduced into LACΔselx using phage 80α [62]. To aid
transduction and allelic replacement, all USA300 mutants were made erythromycin sensitive
by serial passage on TSA. Following transduction, allelic replacement was performed as
described previously [6].
Genomic and phenotypic validation of mutants
Phenotypic analysis and whole genome sequencing was performed on USA300 LAC constructs
(Table 1) to confirm no spurious mutations had occurred (S3 Fig). 250bp Paired End Illumina
HiSeq 2500 reads were mapped to the USA300 FPR3757 (NC_007793) reference genome using
various tools implemented in the Nesoni pipeline (https://github.com/Victorian-Bioinformatics-
Consortium/nesoni). Genome sequence data has been deposited at the European Nucleotide Ar-
chive under study number PRJEB20077 with the accession numbers ERS1625171, ERS1625172,
ERS1625173 and ERS1625174.
Growth curve analysis was performed on a Floustar Omega microplate reader (BMG Lab-
tech, Germany). Overnight cultures of bacteria were diluted 1/100 in either TSB or BHI and
growth was recorded over 18 h. SDS-PAGE analysis was performed on concentrated superna-
tants and cell wall extracts (CWA). To extract CWA proteins, pelleted cells were washed with 1
ml PBS (Oxoid, Cambridge, UK), re-suspended in 1 ml lysis buffer (50 mM TrisHCl, 20 mM
MgCl2, 30% Raffinose (Fluka, UK), adjusted to pH 7.5) containing 200 μg/ml Lysostaphin
(AMBI products LLC, NY, USA) and protease inhibitors (Roche, Switzerland) and incubated
at 37˚C for 20 min. Samples were centrifuged at 6000 x g for 20 min and CWA proteins were
recovered from the supernatant fraction.
S. aureus neutrophil killing assays
S. aureus were cultured to an OD600 of 4.0 in BHI broth, washed by diluting in PBS, followed
by centrifugation at 4000 x g for 10 min. The cells were then diluted to 1x104 CFU/ml in RPMI
containing 10% (v/v) complement-inactivated serum (inactivated by incubation at 56˚C for 30
min). Isolated human neutrophils were infected at a ratio of 1 bacterium to 1000 neutrophils,
and incubated for 60 min at 37˚C with vigorous shaking. 250 μl of the neutrophil bacterial sus-
pension was diluted into 750 μl of PBS containing 0.05% (v/v) Triton-X 100 and incubated for
5 min at room temperature to lyse the neutrophils. A control reaction was also prepared; no
neutrophils were added to the RPMI with heat inactivated serum and treated in the same way
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as the test samples. Viable bacteria in each reaction mixture were enumerated by serial dilution
and plating on to TSA, followed by overnight incubation at 37˚C. Surviving bacteria were
counted and compared to the no neutrophil control to determine bacterial survival.
Phagocytosis assay
Phagocytosis efficacy was measured using FITC-labelled S. aureus USA300 spa::Tn (Table 1),
bacteria were labelled as outlined previously [63]. To determine the level of neutrophil phago-
cytosis, FITC-labelled S. aureus were mixed with complement-inactivated human serum or
purified IgG for 15 min at 37˚C in 2 ml 96-well v-bottomed plates (Corning, USA) to facilitate
opsonisation. Subsequently, isolated human neutrophils, with or without recombinant staphy-
lococcal protein (pre-incubated for 30 min at room temperature), were added at a 10:1 (bacte-
rium/cell) ratio and incubated for 15 min at 37˚C with shaking at 750 rpm. The reaction was
stopped with 1% (v/v) paraformaldehyde (Fisher Scientific, UK), and cell-associated fluores-
cent bacteria were analysed by flow cytometry. Phagocytosis was defined as the percentage of
cells with a positive fluorescent signal. Reduction in phagocytosis was calculated by normalis-
ing the percentage from test samples to that of uninhibited cells for each opsonin.
Cytotoxicity determined by lactate dehydrogenase (LDH) release
Protein mediated cytotoxicity was determined on human neutrophils, this was analysed with
1x105 cells/ml suspended in RPMI 1640 (Gibco, USA) supplemented with 10% heat-inacti-
vated fetal bovine serum (Gemini Bio Products, CA, USA) at a concentration of 1x105 cells/ml.
Recombinant S. aureus proteins were added and incubated for 1 h at 37˚C with 5% CO2. Fol-
lowing protein treatment, cells were pelleted by centrifugation at 450 x g at 4˚C for 5 min. Lac-
tate dehydrogenase (LDH) release was assayed as a measure of neutrophil viability using the
CytoTox-ONE homogeneous membrane integrity assay (Promega, WI, USA) according to the
manufacturer’s specifications. Fluorescence was measured using a PerkinElmer Envision 2103
multilabel reader (excitation, 555 nm; emission, 590 nm) (PerkinElmer, MA, USA), and data
were normalized to 100% lysis as determined by the addition of 0.2% Trition X (v/v) to the
neutrophils.
Affinity precipitation experiments
Detergent-solubilized proteins from primary human neutrophils were incubated with 6 x HIS-
tagged SElX and interacting proteins were purified using Ni-NTA resin (Qiagen, Manchester,
UK). Proteins eluted from Ni-NTA resin were separated by SDS-PAGE (4% to 15% gradient
gel) and stained with SYPRO-Ruby (Life Technologies, UK). Gels were imaged and the lanes
were excised for trypsin digestion, protein extraction and liquid chromatography-tandem
mass spectrometry (LC-MS/MS) analysis as described previously [64].
Enzyme-linked immunosorbent assay (ELISA) analysis
96-well ELISA plates (Maxisorb; Nunc, Thermo, UK) were coated with 10 μg/ml recombinant
SElX, SElX EKQD-A, SSL5 or SSl7 in carbonate/bicarbonate buffer (50 mM Na2CO3 and
NaHCO3 pH 9.6) diluted 1/10 in PBS. The plates were incubated overnight at 4˚C. Plates were
washed with PBS-0.05% (v/v) Tween-20 (Sigma-Aldrich, UK) and blocked with PBS-0.05%
(v/v) Tween-20 and 8% (w/v) skimmed milk powder (microbiology grade; Sigma-Aldrich,
UK) for 1 h at 37˚C. Plates were washed with PBS-0.05% (v/v) Tween20 and incubated with
different concentrations of human CD50-HIS recombinant protein (purchased from Life
Technologies, UK) for 1 h at 37˚C. Bound protein was detected using a specific anti-CD50
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mouse monoclonal antibody (MEM-171; Biorad, UK) and a secondary peroxidase-conjugated
rabbit-anti-mouse monoclonal antibody (Abcam, Cambridge, UK). Peroxidase activity was
detected with 3,30,5,50-Tetramethylbenzidine (TMB) liquid substrate (Sigma-Aldrich, UK) for
40 s and the reaction was stopped using 1M H2SO4. Absorbance was measured at 450 nm
using a Synergy HT plate reader (BioTek, Vermont, USA).
T-cell proliferation assay
Human PBMC were adjusted to a concentration of 1x106 cells/ml in RPMI 1640 (Sigma
Aldrich, UK) supplemented with 10% (v/v) heat-inactivated fetal calf serum (Gibco, UK), 100
U/ml penicillin, 100 μg/ml streptomycin and 292 μg/ml L-glutamine. (PSG) (Gibco, UK). Cells
were cultured in 96-well round bottomed tissue culture plates (Nunc, Fisherbrand, UK) at 37˚C
in humidified air with 5% CO2. Protein samples were tested in triplicate and added at varying
concentrations before incubation. Cells were cultured in medium only or with 1 μg/ml of Con-
canavalin A as negative and positive controls respectively. Proliferation of cells was determined
using the incorporation of [3H]-thymidine, by pulsing with 1 μCi/well of [3H]-thymidine, after
a 72 h incubation, and harvested after 18 h using a Tomtec Mach III M Harvester 96 (Hamden,
USA) onto Wallac A filters (Perkin Elmer, MA, USA). A Meltilex A wax scintillant strip (Perkin
Elmer, MA, USA) was melted onto the filter pad and the [3H]-thymidine incorporation into cel-
lular DNA was determined by scintillation counting using a β-radiation counter (Wallac 1450
Microbeta PLUS, Perkin Elmer) and recorded as counts per minute (CPM).
Rabbit necrotizing pneumonia rabbit model
The rabbit pneumonia model was performed as described previously with some modification
[6]. Briefly, wild-type LAC and the selx mutants (Table 1) were cultured in Todd Hewitt broth
for 16 h and washed once in Todd Hewitt broth. The bacteria were re-suspended in Todd
Hewitt broth at 1×1010 CFU/ml for use in injections. New Zealand White rabbits (3–4 per
group) were anesthetized with ketamine and xylazine. Their tracheas were exposed and a high
(6x109 CFU) or low (2×109 CFU) dose of USA300 CA-MRSA strain LAC or mutant deriva-
tives (Table 1) were administered intra-tracheally through catheters in 0.4 ml volumes. The
animals were closed and monitored for 4 d for development of fatal necrotizing pneumonia.
Murine skin abscess model
Female, inbred 8–12 week old female BALB/cOlaHsd mice aged between 8–12 weeks were
obtained from ENVIGO (UK) and acclimatised for 1 to 2 weeks in the facility before being
used in infection challenge studies. All mice were housed under specific pathogen-free condi-
tions in individually ventilated cages (IVCs) at the Bioresearch Facility (BRF) of the Roslin
Institute (University of Edinburgh, UK). 1 day prior to infection challenge, mice were anesthe-
tized with isoflurane and the fur on the back of each animal was removed by using clippers.
Overnight cultures of S. aureus were inoculated 1:100 into fresh BHI broth and cultured to
mid-log phase (OD600 = 0.6; approximately 2 h) with shaking at 37˚C. Staphylococci were har-
vested by centrifugation, washed, and suspended in sterile PBS to obtain an inoculum of 1x108
CFU/ml. Inocula were determined by CFU enumeration following serial dilution, plating on
TSA plates, and overnight growth at 37˚C. Prior to inoculation the animals were weighed and
then every 24 h post infection. Mice were inoculated with 1x107 CFU by subcutaneous injec-
tion to a depth of 5 mm, in the shaved area of skin on the back of each mouse. Infected animals
were monitored for health status and lesion development over a period of 6 d using a standard-
ized and Home Office project licence approved monitoring protocol. The size of each skin
lesion was measured each day (one measurement across the longest dimension of the lesion).
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Bacterial tissue load was determined post-mortem, the skin lesion was excised, weighed and
homogenised in 1 ml of sterile PBS using fast prep tubes containing lysis matrix D (MP Biome-
dicals, UK). Bacterial loads were determined by CFU enumeration following serial dilution,
plating on TSA plates, and overnight growth at 37˚C. CFU were normalised to tissue weight.
For histopathological analysis lesions were excised and fixed in 10% neutral buffered formalin
(NBF) (Leica microsystems, UK) for 24 h. Lesions were processed to parrifin blocks, sectioned
and then stained with haematoxylin and eosin by the Veterinary Pathology Service Unit of the
Royal (Dick) School of Veterinary Studies (University of Edinburgh).
Statistical analysis
All statistical analysis was performed in Graphpad Prism 7. Grouped data was analysed to deter-
mine if a Gaussian distribution was true with the Shapiro-Wilk normality test. Parametric data
was analysed using student t-test with Welches correction if required. Tests were unpaired and
two-tailed and significant differences were considered when the p-value was<0.05. Protein
dose curves were tested using two-way ANOVA analysis, multiple comparisons were performed
using Sidak’s method. Animal survival curves were plotted using Kaplan-Meier method and sig-
nificance was determined using log-rank (Mantel-Cox) analysis (p-value<0.05).
Supporting information
S1 Fig. Analysis of SElX-binding to different lymphocyte subpopulations. (i) Flow cytome-
tery analysis of SElX binding human neutrophils, monocytes and lymphocytes indicating the
relative binding of SElX to each cell type. SElX binding was determined using a FITC conju-
gate mouse anti-HIS-tag antibody. (ii) Two-colour flow cytometry was used to analyse SElX-
binding to different lymphocyte subpopulations. T-lymphocytes (CD4+ and CD8+), and B-
lymphocytes (CD19+) were concurrently stained with PE-conjugated antibodies directed
against CD4, CD8, or CD19. SElX binding was determined using a FITC conjugate mouse
anti-HIS-tag antibody.
(PDF)
S2 Fig. Mutations in the predicted sialic acid-binding site of SElX have limited impact on
protein structure and stability. Circular dichroism analysis was performed on SElX sialic
acid-binding mutants to ensure that protein structures were not affected by the mutations (i).
Thermal shift assays were performed to analyse protein stability (ii). The Tm of each mutant
was determined by calculating the temperature at which the fluorescence peaked (excitation/
emission/ 470/570 nm).
(PDF)
S3 Fig. Phenotypic and genetic validation of the LACΔselx mutant, LACΔselx rep and LAC
selx EKQD-A strains. (i) Growth curves of S. aureus USA300 mutants (grown at 37˚C for 18h)
in either TSB or BHI broth. (ii) SDS-PAGE analysis of concentrated supernatant and cell wall
associated (CWA) protein fractions at both mid and post exponential growth phases in BHI
broth (1. LAC, 2. LAC selx EKQD-A, 3. LACΔselx rep, 4. LACΔselx). (iii)) Western blot analy-
sis of SElX expression in; (1) LAC, (2) LAC selx EKQD-A, (3) LACΔselx rep and (4) LACΔselx,
with SElX-specific IgY. (iv) Whole genome analysis of each mutant strain was performed,
Black ticks on coloured rings indicate the position of non-synonymous SNPs in wild-type and
the three mutant strains relative to the USA300 FPR3757 (NCBI: NC_007793) chromosome
sequence. SNPs that are not common to all four strains are labelled. Figure panel was gener-
ated using BRIG and custom scripts (PMID: 21824423)
(PDF)
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S4 Fig. SElX does not cause necrosis or apoptosis in human leukocytes. (i) LDH release
assays were performed on human neutrophils to assess the necrotic potential of SElX com-
pared to LukAB, employed as a positive control. Percentage lysis was determined relative to
complete lysis of the neutrophils observed after addition of 0.2% (v/v) Trition-X to the cells.
Results shown are the means of three different human donors, ± SD of the mean. (ii) Analysis
of SElX-induced leukocyte apoptosis using DRAQ5 nuclear stain. Binding assays of SElX and
human leukocytes were performed followed by addition of the nuclear stain DRAQ5 to deter-
mine apoptosis as determined by nuclear fragmentation. Quadrat plots show the binding of
SElX along the X-axis and the Y-axis shows nuclear fragmentation indicated by higher
DRAQ5 fluorescence.
(PDF)
S1 Table. Neutrophil protein ligands of SElX identified by affinity precipitation analysis.
(PDF)
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